Serial 98343323

What this means for you

Not registered yet, but its 05 Jan 2024 filing date beats anything filed after it. If it registers, the owner can stop confusingly similar uses in the classes it covers.

Record

Serial number

98343323

Mark type

Design / logo

Filed

05 Jan 2024

Attorney of record

Anna Kurian Shaw

Goods and services

• Class 035 — Advertising and business services: Promoting collaboration in the field of biotechnology to achieve innovation through increased usage of artificial intelligence (AI) technology; promoting the benefits of the use of artificial intelligence (AI) technology in the field of biotechnology to expedite drug development, optimize laboratory processes, unravel complex biological data, and improve patient outcomes; promotion and advocacy services, namely promoting the benefits of the advancement of biomedical, biotechnological, and immunological research and the curing of various diseases utilizing artificial intelligence (AI) technology, by means of public advocacy; promotion and advocacy services, namely, promoting the benefits of increasing the affordability of and increased access to medical services and the treatment of various diseases, as well as overall patient-centric medical services, utilizing artificial intelligence (AI) technology, by means of public advocacy; promotion and advocacy services, namely promoting the benefit of the treatment of various diseases using T cell therapies and artificial intelligence (AI) technology, by means of public advocacy; promoting collaboration within the scientific, research and medical provider communities to achieve advances in the fields of biotechnology, biomedicine, immunology, immunotherapies, and T-cell therapies utilizing artificial intelligence (AI) technology; business operations consulting in the fields of biotechnology and life sciences; business operations consulting in the fields of biotechnology and life sciences to increase business processes automation and increase the efficiency of business operations procedures; database management in the fields of biotechnology and life sciences; creation being compilation and systemization of information into databases and management of databases in the fields of biotechnology and life sciences; compilation of information into computer databases in the fields of biotechnology and life sciences; systematization of data through a medical device network for medical research purposes; business data analysis in the fields of biotechnology and life sciences; business consulting and management in the field of clinical trials, namely, management and compilation of computerized databases in the field of clinical trials for business purposes; business feasibility study planning, namely, for clinical trials; business study data interpretation, namely, for clinical trials; business consulting and management in the field of clinical trials, namely, clinical data and regulatory submission management on behalf of medical, biopharmaceutical and biotechnology companies to assist them with clinical research, clinical trials and applications for drug approval
• Class 042 — Scientific and technological services: Providing a website featuring news and information concerning biomedical, biotechnological, and immunological research that utilizes artificial intelligence (AI) technology; providing news and information concerning biomedical, biotechnological, and immunological research that utilizes artificial intelligence (AI) technology; providing information concerning biomedical research into the efficacy of T cells and other lymphocytes for the prevention and treatment of various diseases, as enhanced by artificial intelligence (AI) technology; providing medical and scientific research information in the fields of T cell therapies, biologics, pharmaceuticals, and clinical trials that utilize artificial intelligence (AI) technology; providing a website featuring temporary access to non-downloadable computer software for expediting drug development, optimizing laboratory processes, and unravelling complex biological data; providing a website featuring temporary access to non-downloadable computer software for human leukocyte antigen (HLA) specificity mapping; providing a website featuring temporary access to non-downloadable computer software for protein sequencing and genome matching; hosting of non-downloadable computer software for clinical trial and patient information database management; providing online, non-downloadable computer software for machine learning and training of artificial intelligence models in the fields of biomedical, biotechnological, and immunological research; analysis of data from databases in the fields of biotechnology and life sciences; collection of data through a medical device network for medical research purposes; providing an internet-based database for business purposes designed to facilitate complex statistical techniques, programming technologies and validation procedures to support clinical trials containing clinical trial data
• Class 044 — Medical, beauty and agricultural services: Providing a website featuring news and information concerning biotechnology, biomedicine, immunology, immunotherapies, and T-cell therapies that utilize artificial intelligence (AI) technology; providing news and information concerning the prevention and treatment of oncological diseases, autoimmune diseases, neurological diseases, viral infections, and COVID-19 using artificial intelligence (AI) enabled technology; providing information concerning use of T cells and other lymphocytes for the prevention and treatment of various diseases, as enhanced by artificial intelligence (AI) technology

Owner

• Tevogen Bio Inc., Warren, NJ, US

Prosecution history

• 13 Mar 2025 — TEAS CHANGE OF CORRESPONDENCE RECEIVED
• 13 Mar 2025 — ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
• 13 Mar 2025 — TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
• 13 Mar 2025 — APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
• 13 Mar 2025 — TEAS CHANGE OF OWNER ADDRESS RECEIVED
• 22 Oct 2024 — WITHDRAWN FROM PUB - OG REVIEW QUERY
• 01 Oct 2024 — APPROVED FOR PUB - PRINCIPAL REGISTER
• 01 Oct 2024 — EXAMINER'S AMENDMENT ENTERED
• 01 Oct 2024 — NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
• 01 Oct 2024 — EXAMINERS AMENDMENT E-MAILED
• 01 Oct 2024 — EXAMINERS AMENDMENT -WRITTEN
• 10 Sept 2024 — TEAS/EMAIL CORRESPONDENCE ENTERED
• 09 Sept 2024 — CORRESPONDENCE RECEIVED IN LAW OFFICE
• 09 Sept 2024 — TEAS RESPONSE TO OFFICE ACTION RECEIVED
• 06 Aug 2024 — NOTIFICATION OF NON-FINAL ACTION E-MAILED